PHLDA3 and esophageal squamous cell carcinoma: This study demonstrated that BARX2 indirectly activates PHLDA3 transcription, leading to PI3K/AKT suppression and subsequent inhibition of ESCC cell proliferation, migration, invasion, and angiogenesis.